Actoxumab (Anti-Cdiff Toxin A)

Synonyms: Anti-C. difficile Toxin A Recombinant Antibody

Actoxumab ( (Anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB. MW: 145.5 KD.

Actoxumab (Anti-Cdiff Toxin A)

Purity & Quality Control

≥99

Biological Activity

Description Actoxumab ( (Anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB. MW: 145.5 KD.

Product Details

CAS No. 1245634-25-6
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Actoxumab (Anti-Cdiff Toxin A) | Actoxumab (Anti-Cdiff Toxin A) supplier | purchase Actoxumab (Anti-Cdiff Toxin A) | Actoxumab (Anti-Cdiff Toxin A) cost | Actoxumab (Anti-Cdiff Toxin A) manufacturer | order Actoxumab (Anti-Cdiff Toxin A) | Actoxumab (Anti-Cdiff Toxin A) distributor